BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 31622413)

  • 1. Sensitivity and specificity of serum soluble interleukin-2 receptor for diagnosing sarcoidosis in a population of patients suspected of sarcoidosis.
    Eurelings LEM; Miedema JR; Dalm VASH; van Daele PLA; van Hagen PM; van Laar JAM; Dik WA
    PLoS One; 2019; 14(10):e0223897. PubMed ID: 31622413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic Value of Serum-Soluble Interleukin 2 Receptor Levels vs Angiotensin-Converting Enzyme in Patients With Sarcoidosis-Associated Uveitis.
    Groen-Hakan F; Eurelings L; ten Berge JC; van Laar J; Ramakers CRB; Dik WA; Rothova A
    JAMA Ophthalmol; 2017 Dec; 135(12):1352-1358. PubMed ID: 29121154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum soluble interleukin-2 receptor level is more sensitive than angiotensin-converting enzyme or lysozyme for diagnosis of sarcoidosis and may be a marker of multiple organ involvement.
    Thi Hong Nguyen C; Kambe N; Kishimoto I; Ueda-Hayakawa I; Okamoto H
    J Dermatol; 2017 Jul; 44(7):789-797. PubMed ID: 28295528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ACE and sIL-2R correlate with lung function improvement in sarcoidosis during methotrexate therapy.
    Vorselaars AD; van Moorsel CH; Zanen P; Ruven HJ; Claessen AM; van Velzen-Blad H; Grutters JC
    Respir Med; 2015 Feb; 109(2):279-85. PubMed ID: 25496652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. YKL-40, Soluble IL-2 Receptor, Angiotensin Converting Enzyme and C-Reactive Protein: Comparison of Markers of Sarcoidosis Activity.
    Uysal P; Durmus S; Sozer V; Gelisgen R; Seyhan EC; Erdenen F; Simsek G; Uzun H
    Biomolecules; 2018 Aug; 8(3):. PubMed ID: 30154391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 18F-FDG PET, genotype-corrected ACE and sIL-2R in newly diagnosed sarcoidosis.
    Keijsers RG; Verzijlbergen FJ; Oyen WJ; van den Bosch JM; Ruven HJ; van Velzen-Blad H; Grutters JC
    Eur J Nucl Med Mol Imaging; 2009 Jul; 36(7):1131-7. PubMed ID: 19259660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myeloid marker S100A8/A9 and lymphocyte marker, soluble interleukin 2 receptor: biomarkers of hidradenitis suppurativa disease activity?
    Wieland CW; Vogl T; Ordelman A; Vloedgraven HG; Verwoolde LH; Rensen JM; Roth J; Boer J; Hessels J
    Br J Dermatol; 2013 Jun; 168(6):1252-8. PubMed ID: 23320892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical diagnostic value of serum soluble IL-2 receptor for stage I sarcoidosis in benign isolated mediastinal and hilar lymphadenopathy.
    Chen W; Zhang Q; Li M; Huang G; Guo L; Chen Z; Ding Q; Gu Y
    Clin Chim Acta; 2023 May; 545():117372. PubMed ID: 37127231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative evaluation of serum markers in pulmonary sarcoidosis.
    Miyoshi S; Hamada H; Kadowaki T; Hamaguchi N; Ito R; Irifune K; Higaki J
    Chest; 2010 Jun; 137(6):1391-7. PubMed ID: 20081103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of Combined Measurement of Serum Soluble IL-2R and Angiotensin-Converting Enzyme in the Detection of Uveitis Associated with Japanese Sarcoidosis.
    Ishihara M; Meguro A; Ishido M; Takeuchi M; Shibuya E; Mizuki N
    Clin Ophthalmol; 2020; 14():2311-2317. PubMed ID: 32848359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of serum soluble interleukin-2 receptor as a diagnostic and predictive biomarker in sarcoidosis.
    Schimmelpennink MC; Quanjel M; Vorselaars A; Wiertz I; Veltkamp M; Van Moorsel C; Grutters JC
    Expert Rev Respir Med; 2020 Jul; 14(7):749-756. PubMed ID: 32248706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined application of angiotensin converting enzyme and chitotriosidase analysis improves the laboratory diagnosis of sarcoidosis.
    Enyedi A; Csongrádi A; Altorjay IT; Beke GL; Váradi C; Enyedi EE; Kiss DR; Bányai E; Kalina E; Kappelmayer J; Tóth A; Papp Z; Takács I; Fagyas M
    Clin Chim Acta; 2020 Jan; 500():155-162. PubMed ID: 31672631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of spleen metabolism assessed by 18F-FDG PET with serum interleukin-2 receptor levels and other biomarkers in patients with untreated sarcoidosis.
    Kalkanis A; Kalkanis D; Drougas D; Vavougios GD; Datseris I; Judson MA; Georgiou E
    Nucl Med Commun; 2016 Mar; 37(3):273-7. PubMed ID: 26544095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble interleukin-2 receptor in blood from patients with sarcoidosis and idiopathic pulmonary fibrosis.
    Tsutsumi T; Nagai S; Imai K; Setoyama Y; Uchiyama T; Izumi T
    Sarcoidosis; 1994 Sep; 11(2):102-9. PubMed ID: 7809492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sarcoidosis: TNF-alpha release from alveolar macrophages and serum level of sIL-2R are prognostic markers.
    Ziegenhagen MW; Benner UK; Zissel G; Zabel P; Schlaak M; Müller-Quernheim J
    Am J Respir Crit Care Med; 1997 Nov; 156(5):1586-92. PubMed ID: 9372680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble Interleukin-2 Receptor: A Potential Marker for Monitoring Disease Activity in IgG4-Related Disease.
    Karim AF; Eurelings LEM; Bansie RD; van Hagen PM; van Laar JAM; Dik WA
    Mediators Inflamm; 2018; 2018():6103064. PubMed ID: 29686532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-2 Receptor and Angiotensin-Converting Enzyme as Markers for Ocular Sarcoidosis.
    Gundlach E; Hoffmann MM; Prasse A; Heinzelmann S; Ness T
    PLoS One; 2016; 11(1):e0147258. PubMed ID: 26799486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of systemic parameters for the diagnosis of ocular sarcoidosis.
    Suzuki K; Namba K; Mizuuchi K; Iwata D; Ito T; Hase K; Kitaichi N; Ishida S
    Jpn J Ophthalmol; 2021 Mar; 65(2):191-198. PubMed ID: 33420542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum soluble interleukin-2 receptor measurement in patients with sarcoidosis: a clinical evaluation.
    Grutters JC; Fellrath JM; Mulder L; Janssen R; van den Bosch JM; van Velzen-Blad H
    Chest; 2003 Jul; 124(1):186-95. PubMed ID: 12853522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conventional markers in determination of activity of sarcoidosis.
    Gungor S; Ozseker F; Yalcinsoy M; Akkaya E; Can G; Eroglu H; Genc NS
    Int Immunopharmacol; 2015 Mar; 25(1):174-9. PubMed ID: 25623898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.